Overweight and Obesity Clinical Trial
— PREPARE CHILDOfficial title:
PRE-Pregnancy Weight Loss And the Reducing Effect on CHILDhood Overweight - Aarhus
The study is a single site parallel randomized controlled study. The study will be assessing the effect of a 10% pre-conceptional weight loss intervention vs a control group among healthy couples where the prospective mother is pregnant and overweight or obese (BMI 27-44.9 kg/m^2). The couples in intervention group will receive dietitian counseling and participate in physical activity sessions to attain the 10% weight loss. The overall objective is to test whether a comprehensive pre-conceptional parental weight loss intervention effectively reduces the risk of offspring overweight, and adiposity and its complications compared to a control group.
Status | Recruiting |
Enrollment | 140 |
Est. completion date | April 11, 2028 |
Est. primary completion date | April 11, 2025 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 38 Years |
Eligibility | Maternal inclusion Criteria: - Maternal pre-pregnancy BMI 27.0-44.9 kg/m^2 - Maternal age range 18-38 years - Connected to Aarhus University Hospital as place of birth - Pregnant Paternal Inclusion Criteria: - Paternal pre-pregnancy BMI 18.5-44.9 kg/m^2 - Paternal age range 18-55 years Parental Inclusion Criteria: - Couples (male and female) - Planning pregnancy within 3 years - Provided voluntary informed consent - Danish or English speaking - Intention to permit the planned offspring to participate in the follow-up study - Able to store biological samples from the offspring at home in the freezer in a box given by the study personnel Parental Exclusion Criteria: - Diabetes mellitus (Type 1 or 2) - Previous or present eating disorder - Allergy towards ingredients in the very low calorie diet products - Severe heart, liver or kidney disease - Conception by in vitro fertilization - Any medical condition or concomitant medication as judged by the medical responsible - Adherence to vegan diets or other diets interfering with the dietary guidelines in the study - Participation in other clinical trial that can affect the results of the current study - Engagement in elite sports or similar strenuous exercise =5 h/week at inclusion - Blood donation or transfusion within the past month before screening - Blood donation during the study - Inability or unwillingness to follow the study protocol and instructions given by the study personnel A detailed description of the exclusion criteria is given below: Medical conditions as known by the participant: - Diabetes mellitus (type 1 and 2) - History or diagnosis of eating disorder (e.g. restrained eating, disinhibition, emotional eating) - Any significant medical condition as assessed by the investigator (e.g. dysregulated thyroid disease or reproductive diseases) - Any significant psychiatric disorder (i.e. schizophrenia, bipolar disease or depression) as assessed by the investigator - Severe chronic heart, liver and kidney disease - Polycystic ovary syndrome with irregular cycle Medication: - Current use of medication or use within the previous three months with a potential to affect body weight or pregnancy as judged by the investigator (e.g. systemic corticoids) Personal/other: - Severe food allergies, food intolerances or dislike expected to interfere with the study, including allergy towards ingredients in the VLCD products - Engagement in elite sports or similar strenuous exercise =5 h/week - Blood donation or transfusion within the past month before screening - Planned blood donation for other purpose than this study during participation - Alcohol abuse, as judged by the investigator, within the previous 12 months - Drug abuse, as judged by the investigator, within the previous 12 months - Psychological or behavioral problems which, in the judgement of the investigator, would lead to difficulty in complying with the study protocol - Participation in other clinical trials within the past three months or intention to do so during the study, which are judged by the investigator to affect the present study - Unable to consume the interventional product for religious reasons, swallowing disorders, other physiological reasons or any other reasons for not being able to follow the recommended diet - Inability or unwillingness to give written informed consent or communicate with study personnel - Inability or unwillingness to follow the study protocol and instructions given by the study personnel - Illiteracy or inadequate understanding of Danish or English language. - Any other condition that judged by the investigator may interfere with the adherence to the study protocol |
Country | Name | City | State |
---|---|---|---|
Denmark | Aarhus University Hospital | Aarhus |
Lead Sponsor | Collaborator |
---|---|
Ulla Kampmann Opstrup | Jens Meldgaard Bruun, Professor Steno Diabetes Center Aarhus, Aarhus University Hospital, Per Ovesen, Professor Dept. of Obsteterics, Aarhus University Hospital, Sine Knorr, PhD Steno Diabetes Center Aarhus, Aarhus University Hospital |
Denmark,
Rasmussen L, Knorr S, Antoniussen CS, Bruun JM, Ovesen PG, Fuglsang J, Kampmann U. The Impact of Lifestyle, Diet and Physical Activity on Epigenetic Changes in the Offspring-A Systematic Review. Nutrients. 2021 Aug 17;13(8):2821. doi: 10.3390/nu13082821. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Offspring feces - Microbiome | Will be analysed for microbiome. Collected at birth by researcher and home by parents preferable <24 hours before the planned visit. | Collected within the first week after birth (but should avoid to collect the first fecal excretion after birth (meconium)), at study visit 3 and 12 months after birth of each offspring | |
Other | Offspring feces - Short chain fatty acids | Will be analysed for short chain fatty acids. Collected at birth by researcher and home by parents preferable <24 hours before the planned visit. | Collected within the first week after birth (but should avoid to collect the first fecal excretion after birth (meconium)), at study visit 3 and 12 months after birth of each offspring | |
Other | Offspring feces - Metabolomics | Will be analysed for metabolomics. Collected at birth by researcher and home by parents preferable <24 hours before the planned visit. | Collected within the first week after birth (but should avoid to collect the first fecal excretion after birth (meconium)), at study visit 3 and 12 months after birth of each offspring | |
Other | Offspring feces - Proteomics | Will be analysed for proteomics. Collected at birth by researcher and home by parents preferable <24 hours before the planned visit. | Collected within the first week after birth (but should avoid to collect the first fecal excretion after birth (meconium)), at study visit 3 and 12 months after birth of each offspring | |
Other | Offspring feces - pH | Will be assessed for pH. Collected at birth by researcher and home by parents preferable <24 hours before the planned visit. | Collected within the first week after birth (but should avoid to collect the first fecal excretion after birth (meconium)), at study visit 3 and 12 months after birth of each offspring | |
Other | Offspring feces - Inflammation markers | Will be analysed for inflammation markers. Collected at birth by researcher and home by parents preferable <24 hours before the planned visit. | Collected within the first week after birth (but should avoid to collect the first fecal excretion after birth (meconium)), at study visit 3 and 12 months after birth of each offspring | |
Other | Offspring feces - consistency | Whenever a fecal sample is collected stool consistency of the collected sample will be collected with a questionnaire. | Collected within the first week after birth (but should avoid to collect the first fecal excretion after birth (meconium)), at study visit 3 and 12 months after birth of each offspring | |
Other | Offspring feces - frequency | Whenever a fecal sample is collected an estimate of stool frequency during the last week will be collected with a questionnaire. | Collected within the first week after birth (but should avoid to collect the first fecal excretion after birth (meconium)), at study visit 3 and 12 months after birth of each offspring | |
Other | Offspring feces - gastrointestinal symptoms | Whenever a fecal sample is collected any gastrointestinal symptoms of the offspring during the last week will be collected with a questionnaire. | Collected within the first week after birth (but should avoid to collect the first fecal excretion after birth (meconium)), at study visit 3 and 12 months after birth of each offspring | |
Other | Offspring urine | Parents will be instructed to collect offspring's urine samples. A piece of bio-plastic will be placed in the diaper together with cotton balls to ensure that a sufficient amount of urine is absorbed into the cotton balls. Offspring urine will be analyzed for metabolomics. | Collected within the first week of birth and at 3 and 12 months follow up of each offspring | |
Other | Adult feces - Microbiome | Participants will collect a fecal spot sample at home maximum 24 hours before the planned visit.
Will be analysed for microbiome. |
Collected at GA34-GA36 in each pregnancy and at study visit 3, 12 and 24 months pp of 1st child | |
Other | Adult feces - Short chain fatty acids | Participants will collect a fecal spot sample at home maximum 24 hours before the planned visit. Will be analysed for short chain fatty acids. | Collected at GA34-GA36 in each pregnancy and at study visit 3, 12 and 24 months pp of 1st child | |
Other | Adult feces - Metabolomics | Participants will collect a fecal spot sample at home maximum 24 hours before the planned visit.
Will be analysed for metabolomics |
Collected at GA34-GA36 in each pregnancy and at study visit 3, 12 and 24 months pp of 1st child | |
Other | Adult feces - Proteomics | Participants will collect a fecal spot sample at home maximum 24 hours before the planned visit.
Will be analysed for proteomics. |
Collected at GA34-GA36 in each pregnancy and at study visit 3, 12 and 24 months pp of 1st child | |
Other | Adult feces - Inflammation markers | Participants will collect a fecal spot sample at home maximum 24 hours before the planned visit.
Will be analysed for inflammation markers. |
Collected at GA34-GA36 in each pregnancy and at study visit 3, 12 and 24 months pp of 1st child | |
Other | Adult feces - pH | Participants will collect a fecal spot sample at home maximum 24 hours before the planned visit.
Will be assessed for pH. |
Collected at GA34-GA36 in each pregnancy and at study visit 3, 12 and 24 months pp of 1st child | |
Other | Adult feces - consistency | Whenever a fecal sample is collected stool consistency of the collected sample will be collected with a questionnaire. | Collected at GA34-GA36 in each pregnancy and at study visit 3, 12 and 24 months pp of 1st child | |
Other | Adult feces - frequency | Whenever a fecal sample is collected an estimate of stool frequency during the last week will be collected with a questionnaire. | Collected at GA34-GA36 in each pregnancy and at study visit 3, 12 and 24 months pp of 1st child | |
Other | Adult feces - gastrointestinal symptoms | Whenever a fecal sample is collected gastrointestinal symptoms during the last week will be collected with a questionnaire. | Collected at GA34-GA36 in each pregnancy and at study visit 3, 12 and 24 months pp of 1st child | |
Other | Adult urine | Participants will collect a urine spot sample at the study site. Adult urine will be analyzed for metabolomics. | Collected at GA34-GA36 in each pregnancy and at study visit 3, 12 and 24 months pp of 1st child | |
Other | Offspring nutritional milestones | Parents will be instructed to register the age of the offspring when it reaches the World Health Organization (WHO) nutritional milestones (age when the offspring was introduced to specific food items) | Collected at 12 and 18 months after offspring birth | |
Other | Offspring development, WHO milestones | Parents will be instructed to register the age of the offspring when it reaches the World Health Organization (WHO) developmental milestones (age when the offspring can sit, stands in crawl-position, stands with support, stand alone, walk with support, walk alone) | Collected at 12 and 18 months after offspring birth | |
Other | Adult physical activity | Physical activity and sleep will be assessed by an accelerometer and the females and males will wear the accelerometer for 7 days and 8 nights. The participants will be asked to keep a physical activity and sleep log for when they wake up and when they try to sleep | Collected at study visit 3, 12 and 24 months pp of 1st child | |
Other | Adult physical activity - Physical Activity Questionnaire (IPAQ) | Physical activity will be assessed by the International Physical Activity Questionnaire (IPAQ), in which time spent on strenuous and moderate activity and walks will be collected. The answers will be collected electronic via RedCap. | Collected at GA34-GA36 in each pregnancy, study visit at 3, 12 and 24 months pp of 1st child and 3 months pp visit after 2nd child | |
Other | Adult background quistionnaire, ethnicity, | All information will be collected electronic in RedCap. | Collected after screening in GA34-GA36 of 1st child | |
Other | Adult background quistionnaire, education | All information will be collected electronic in RedCap. | Collected after screening in GA34-GA36 of 1st child | |
Other | Adult background quistionnaire, parity | All information will be collected electronic in RedCap. | Collected after screening in GA34-GA36 of 1st child | |
Other | Adult background quistionnaire, pre-pregnancy weight | Pre-pregnancy weight, ethnicity, education and parity. All information will be collected electronic in RedCap. | Collected after screening in GA34-GA36 of 1st child | |
Other | Adult background quistionnaire, demographic information | All information will be collected electronic in RedCap. | Collected after screening in GA34-GA36 of 1st child | |
Other | Adult wellbeing - Depression, Major depression questionnaire (ICD-10) | Depression will be assessed by Major depression questionnaire (ICD-10). Mild depression: A score of 4 or 5 in two of the first three items. Plus a score of at least 3 on two or three of the last seven items.
Moderate depression: A score of 4 or 5 in two or three of the first three items. Plus a score of at least 3 on four of the last seven items. Severe depression: A score of 4 or 5 in all of the first three items. Plus a score of at least 3 on five or more of the last seven items. Major depression: The number of items is reduced to nine, as Item 4 is part of Item 5. Include whichever of the two items has the highest score (item 4 or 5). A score on at least five items is required, to be scored as follows: the score on the first three items must be at least 4, and on the other items at least 3. Either Item 1 or 2 must have a score of 4 or 5. |
Collected at GA34-GA36 in each pregnancy, study visit at 3, 12 and 24 months pp of 1st child and 3 months pp visit after 2nd child | |
Other | Adult wellbeing - Quality of life, Short form-36 (SF-36) | Quality of life will be assessed by the validated tool, Short form-36 (SF-36). The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability. | Collected at GA34-GA36 in each pregnancy, study visit at 3, 12 and 24 months pp of 1st child and 3 months pp visit after 2nd child | |
Other | Adult wellbeing - Stress, Perceived Stress Scale | Stress will be assessed by validated tool, Perceived Stress Scale.Individual scores on the PSS can range from 0 to 40 with higher scores indicating higher perceived stress. Scores ranging from 0-13 would be considered low stress. Scores ranging from 14-26 would be considered moderate stress. Scores ranging from 27-40 would be considered high perceived stress | Collected at GA34-GA36 in each pregnancy, study visit at 3, 12 and 24 months pp of 1st child and 3 months pp visit after 2nd child | |
Other | Adult sleep | Sleep will be assessed by the validated tool, Pittsburgh sleep quality index questionnaire (PSQI). In scoring the PSQI, seven component scores are derived, each scored 0 (no difficulty) to 3 (severe difficulty). The component scores are summed to produce a global score (range 0 to 21). Higher scores indicate worse sleep quality. | Collected at GA34-GA36 in each pregnancy, study visit at 3, 12 and 24 months pp of 1st child and 3 months pp visit after 2nd child | |
Other | Adult dietary intake, 24-h recall | A 24 hour dietary recall is performed by a trained dietitian. Dietary recall will be registered and intake calculated using the food data program 'VITAKOST' (www.vitakost.dk). | Collected at GA34-GA36 in each pregnancy, at visit 3, 12 and 24 months pp of the 1st child and 3 months visit after 2nd child. Further collected at 6, 18, 30 and 36 months pp and in GA12 and GA20 of 2nd pregnancy in intervention group | |
Other | Adult dietary intake, FFQ | Couples will be asked to perform an electronic Food Frequency Questionnaire (FFQ). Information on frequence intake of various food groups during the last month will be collected. | Collected at GA34-GA36 in each pregnancy, at study visit 3, 12 and 24 months pp of the 1st child and 3 month follow up vist after 2nd child | |
Other | Offspring dietary intake | We will collect information on offspring dietary intake including breast feeding, use of formula and type as well as use of antibiotics. The intake frequency of different foods will be collected throughout a children questionnaire. | Collected within the first week of birth and 3, 12 and 18 months after birth off each offspring | |
Other | Breast milk - nutrients biomarkers | Participants will collect breast milk within the first week following birth, at 1 and 3 months pp after each birth. Participants will receive written instructions in milk collection at home. First drops will not be collected, hereafter manually expressed milk will be obtained in a sterile container. Obtained around midday and minimum two hours after last breastfeeding. Breast milk will be analyzed for nutrients biomarkers. | Collected within the first week of birth and 3 months pp after each birth | |
Other | Breast milk - Hormonal and inflammatory markers | Participants will collect breast milk within the first week following birth, at 1 and 3 months pp after each birth. Participants will receive written instructions in milk collection at home. First drops will not be collected, hereafter manually expressed milk will be obtained in a sterile container. Obtained around midday and minimum two hours after last breastfeeding. Breast milk will be analyzed for hormonal and inflammatory markers | Collected within the first week of birth and 3 months pp after each birth | |
Other | Breast milk - Metabolomics | Participants will collect breast milk within the first week following birth, at 1 and 3 months pp after each birth. Participants will receive written instructions in milk collection at home. First drops will not be collected, hereafter manually expressed milk will be obtained in a sterile container. Obtained around midday and minimum two hours after last breastfeeding. Breast milk will be analyzed for metabolomics | Collected within the first week of birth and 3 months pp after each birth | |
Other | Breast milk - Proteomics | Participants will collect breast milk within the first week following birth, at 1 and 3 months pp after each birth. Participants will receive written instructions in milk collection at home. First drops will not be collected, hereafter manually expressed milk will be obtained in a sterile container. Obtained around midday and minimum two hours after last breastfeeding. Breast milk will be analyzed for proteomics. | Collected within the first week of birth and 3 months pp after each birth | |
Other | Breast milk - Short chain fatty acids and related metabolites | Participants will collect breast milk within the first week following birth, at 1 and 3 months pp after each birth. Participants will receive written instructions in milk collection at home. First drops will not be collected, hereafter manually expressed milk will be obtained in a sterile container. Obtained around midday and minimum two hours after last breastfeeding. Breast milk will be analyzed for short chain fatty acids and related metabolites | Collected within the first week of birth and 3 months pp after each birth | |
Other | Adult participation - dietitian guidance | It will be recorded how many times of individual and group dietitian guidance the participant attends | Every 1-2 month from 3 months pp of 1st child to birth of 2nd child | |
Other | Adult participation - physical session and power walk | It will be recorded how many times the participant participates in physical activity sessions and how much the person have power walked | Every 2nd week from 3 months pp of 1st child to birth of 2nd child | |
Primary | Neonatal fat mass | Offspring's neonatal fat mass (grams) assessed by air displacement plethysmography (Pea POD) | Collected within the first week of birth (strived <48 hours) | |
Primary | Difference in epigenetic changes in child 1 and 2 | Cord blood from offspring will be collected at birth and stored at -80 °C until use. At the Department of Molecular Medicine AUH genomic DNA will be extracted from peripheral blood using standard methods e.g., QIAmp® Mini Kit (Qiagen, Germany). 1 µg of genomic DNA will be bisulfide converted using Illumina iScan (platform). The methylation level will be measured using Infinium MethylationEPIC DNA Analysis BeadChip (Array type) at Eurofins Genomics AS (Denmark) or similar methods.
The stated required sample size (140 couples) is calculated based on the neonatal fat mass. As no other studies have performed methylation analysis using WGBS in similar cohorts, precise power calculations on epigenetic changes are impractical. However, since the EPICOM study found differentially methylated regions in only 20 cases and 20 controls using Illumina's 450K methylation assay, the power to elucidate epigenetic changes is considered sufficient in the planned study. |
Assessed at birth | |
Secondary | Obstetrics outcome - length of gestational age | Length of gestational age | Assessed at birth of both offsprings | |
Secondary | Obstetric - medication use | Medication use during labor | Collected from initiation of labor until completed birth of both offsprings | |
Secondary | Obstetric - delivery mode | Delivery mode (rupture of membranes or premature contractions, vaginal, cesarean section, instrumental delivery, miscarriage and stillbirth). | Collected at birth of both offsprings | |
Secondary | Obstetric - pregnancy complications | Pregnancy complications e.g. miscarriage, abortion (induced and indication for abortion), hydramnios, gestational hypertension, preeclampsia, need for maternal corticosteroid treatment for fetal lung maturation, urinary tract infection) will be collected from medical record. | Collected at gestational age (GA) 34-36 and after birth of both offsprings | |
Secondary | Obstetric - Neonatal unit admissions | Neonatal unit admissions | Collected at birth and until 12 months after birth of both offsprings | |
Secondary | Obstetric - obstetrics complications | Obstetrics complications (e.g. preterm prelabour rupture of the membranes, shoulder dystocia, birth trauma (perinatal rupture), postpartum hemorrhage, maternal infections, maternal hospitalization). | Collected at birth of both offsprings | |
Secondary | Obstetrics - birth defects/abnormalities | Birth defects/abnormalities | Collected at birth of both offsprings | |
Secondary | Neonatal morbidities | Neonatal morbidity (e.g. major congenital malformations (ICD10 Q00-Q99 or requiring medical or surgical treatment), birth injury, respiratory distress, transient tachypnoea, neonatal hypoglycemia, systemic infections, admission to neonatal intensive care unit, number of admission days, hyperbilirubinemia), deaths. | Collected at birth of both offsprings | |
Secondary | Fetal and offspring growth - body weight | Fetal body weight will be measured with ultrasound during pregnancy and offspring body weight will be measured using an electronic scale. | Collected from medical record during pregnancy, measured in gestational age (GA) GA34-GA36 via ultrasound in both pregnancies, at birth and 3, 12 and 18 months after birth of both offsprings | |
Secondary | Fetal and offspring growth - length | Fetal length will be measured with ultrasound during pregnancy and offspring length will be measured using an infantometer as appropriate for measuring infant, baby and toddler length. | Collected from medical record during pregnancy, measured in GA34-GA36 via ultrasound in both pregnancies, and measured at birth and 3, 12 and 18 months after birth of both offsprings | |
Secondary | Fetal and offspring growth - abdominal circumference | Abdominal circumference will be measured with ultrasound during pregnancy and offspring abdominal circumference will be measured three times to the nearest 0.1 cm using a stretch-resistant measuring tape | Collected from medical record during pregnancy, measured in GA34-GA36 via ultrasound in both pregnancies, and measured at birth and 3, 12 and 18 months after birth of both offsprings | |
Secondary | Fetal and offspring growth - crown circumference | Crown circumference will be measured with ultrasound during pregnancy | Collected from medical record during pregnancy, measured in GA34-GA36 via ultrasound in both pregnancies | |
Secondary | Fetal and offspring growth - femur length | Femur length will be measured with ultrasound during pregnancy | Collected from medical record during pregnancy, measured in GA34-GA36 via ultrasound in both pregnancies, | |
Secondary | Fetal growth - fractional limb volume | Fractional limb volume will be measured with ultrasound during pregnancy | Collected from medical record during pregnancy, measured in GA34-GA36 via ultrasound in both pregnancies, | |
Secondary | Offspring growth - BMI z-score | Offspring body mass index (BMI) z-score (BMI adjusted for age and sex). | Collected at birth and 3, 12 and 18 months after birth of both offsprings | |
Secondary | Offspring growth - weight for gestational age | Weight for gestational age. Measured as percent of normal weight related to gestational age. | Collected at birth and 3, 12 and 18 months after birth of both offsprings | |
Secondary | Offspring growth - large for gestational age | Large for gestational age. Prevalence of infants being large for gestational age (LGA). | Collected at birth of both offsprings | |
Secondary | Offspring growth - small for gestational age | Small for gestational age. Prevalence of offspring being small for gestational age (SGA). | Collected at birth of both offsprings | |
Secondary | Offspring growth - apgar score | Apgar score (0-10). The higher the score, the better health condition of the offspring) | Collected at birth of offspring of both offsprings | |
Secondary | Offspring growth | Offspring circumference (thigh and upper arm) and skinfold (triceps, subscapularis and suprailiac). Circumferences will be measured to the nearest 0.1 cm using a stretch-resistant measuring tape and skinfolds are measured to the nearest 0.02 cm using a caliper to lightly pinch the skin and the underlying fat. | Collected at birth and 3, 12 and 18 months after birth of offspring. | |
Secondary | Offspring growth - body composition by the POD system | Offspring fat free mass (g) and fat mass (g) will be assessed by air displacement plethysmography using the POD system (Pea POD for 1-8kg) | Collected within the first week of birth and 3 months post partum in both offsprings | |
Secondary | Offspring blood pressure | Offspring blood pressure (diastolic and systolic blood pressure) will be measured three times after 10 minutes rest using an automated device placed on the arm and in direct contact with the skin. | Collected 12 and 18 months after birth of both offsprings | |
Secondary | Offspring heart rate | Offspring heart rate will be measured three times after 10 minutes rest using an automated device placed on the arm and in direct contact with the skin. | Collected 12 and 18 months after birth of both offsprings | |
Secondary | Offspring growth - self-reported body weight | Self-reported body weight | 18 months after birth the study staff will make an annual follow-up phone call to the parents to collect information about the offspring's self-reported body weight until the offspring is 18 of age | |
Secondary | Offspring growth - self-reported height | Self-reported height | 18 months after birth the study staff will make an annual follow-up phone call to the parents to collect information about the offspring's self-reported body weight until the offspring is 18 of age | |
Secondary | Adult weight | Adult body weight is measured to the nearest 0.1 kg using a calibrated scale | Intervention: each visit throughout study (GA34-36 of 1st child to 18mo. after birth of 2nd child). Control: In GA34-36 in both pregnancies, at study visits (3, 12 and 24mo. pp) and follow up visits (3, 12 and 18 months pp of 2nd child) | |
Secondary | Adult Height | Adult height will be measured to the nearest 0.5 cm using a wall-mounted stadiometer. | Collected in GA34-GA36 in index pregnancy | |
Secondary | Adult BMI | Calculated as weight (kg)/height(m)^2 | Collected in GA34-36 in 1st pregnancy, study visits 3, 12 and 24mo. pp after 1st child, GA34-36 in 2nd pregnancy and at follow up vist (3, 12 and 18mo. pp of 2nd child). | |
Secondary | Adult anthropometric | Waist- and hip circumference will be measured to the nearest 0.1 cm. During pregnancy and at birth the waist of the female will not be measured. | Intervention: each visit throughout study (GA34-36 of 1st child to 18mo. after birth of 2nd child). Control: In GA34-36 in both pregnancies, at study visits (3, 12 and 24mo. pp) and follow up visits (3, 12 and 18 months pp of 2nd child) | |
Secondary | Adult blood pressure | Blood pressure (diastolic and systolic blood pressure) will be measured three times with two minutes apart in right arm after 15 minutes rest using a validated automatic device. The reading is recorded to the nearest 1 mmHg. | Collected at GA34-36 in 1st pregnancy, study visits 3, 12 and 24 months pp. of 1st child, GA34-36 in 2nd pregnancy and 3 months pp after 2nd child | |
Secondary | Adult heart rate | Heart rate will be measured three times with two minutes apart in right arm after 5-10 minutes rest using a validated automatic device. The reading is recorded to the nearest 1 beats/minute for heart rate | Collected at GA34-36 in 1st pregnancy, study visits 3, 12 and 24 months pp. of 1st child, GA34-36 in 2nd pregnancy and 3 months pp after 2nd child | |
Secondary | Adult resting metabolic rate | Resting metabolic rate (calories/24-h) will be measured by indirect calorimetry using a ventilated hood system. Participants will lie in the supine position and rest for at least 30 min before measurements commence. The measurement will last for 20 min. | Collected at study visit 3, 12, and 24 months pp after 1st child. | |
Secondary | Adult resting respiratory quotient + substrate | Resting respiratory quotient (RQ), will be measured by indirect calorimetry using a ventilated hood system. Participants will lie in the supine position and rest for at least 30 min before measurements commence. The measurement will last for 20 min. Lipid, glucose and protein oxidation will be estimated. | Collected at study visit 3, 12, and 24 months pp after 1st child. | |
Secondary | Adult medication use | Use of medication will be collected throughout the study and for each medication the start date, stop date or continuing, form and indication will be noted in appropriate form. | Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st. child | |
Secondary | Offspring medication use | Use of medication will be collected throughout the study and for each medication the start date, stop date or continuing, form and indication will be noted in appropriate form. | Birth, after 3, 12, and 18 months after birth of both offsprings | |
Secondary | Adult reproduction - Time to pregnancy | Duration of time to conception defined from selfreported time point they started to try get pregnant to registration of pregnancy. The time of conception will be calculated from the ultrasound scan in week 12 | Registration of 2nd. pregnancy (up to tree years from birth of 1.st. child) | |
Secondary | Adult glucose metabolism (OGTT) | 3-h oral glucose tolerance test (OGTT) will be performed at with 75g of glucose dissolved in 250 ml of water and added 1 gram of paracetamol. Blood will collected for measurements of blood glucose, hormones (insulin, C-Peptide, glucagon), paracetamol, glucagon-like-peptide-1 (GLP-1), Glucose insulinotropic polypeptide (GIP) and metabolites (FFA). Blood samples will be drawn at time 0, 15, 30, 45, 60, 90, 120 and 180 min | Performed at study visits 3, 12 and 24 months pp of 1st. child | |
Secondary | Adult Oral Glucose Tolerance Test (OGTT) during pregnancy (only female) | OGTT performed during pregnancy according to the screening guidelines for GDM will be obtained from the mother's medical journal in both pregnancies. | Collected in GA28 of 1st and 2nd pregnancy (performed after risk score at gestational age~20 and ~28 or only ~28) | |
Secondary | Placenta - weight (gram) | Placenta will be weighted after birth | Collected at birth of both offsprings | |
Secondary | VO2-max adult - cardiorespiratory fitness | The VO2-max test will be performed as an incremental exercise test on a bicycle ergometer. | Collected at study visit 3, 12 and 24 months pp after birth of 1st child | |
Secondary | Cardiac function offspring - Left ventricular and right ventricular morphology | ECG and echocardiography will be performed according to standard imaging protocol. Assessment of Interventricular septal thickness diastole and valve- and chamber dimensions will be done. | Collected at birth and at 12 months follow up visit after birth of each child | |
Secondary | Cardiac function offspring - left centricular ejection fraction | ECG and echocardiography will be performed according to standard imaging protocol. Assessment of left ventricular ejection fraction will be done. | Collected at birth and at 12 months follow up visit after birth of each child | |
Secondary | Cardiac function offspring - fractional shortening | ECG and echocardiography will be performed according to standard imaging protocol. Assessment of fractional shortening will be done. | Collected at birth and at 12 months follow up visit after birth of each child | |
Secondary | Cardiac function offspring - Systolic function, strain | ECG and echocardiography will be performed according to standard imaging protocol. Assessment of strain will be done. | Collected at birth and at 12 months follow up visit after birth of each child | |
Secondary | Cardiac function offspring - Systolic function, strain rate | ECG and echocardiography will be performed according to standard imaging protocol. Assessment of strain rate will be done. | Collected at birth and at 12 months follow up visit after birth of each child | |
Secondary | Cardiac function offspring - TAPSE and RV fractional area change | ECG and echocardiography will be performed according to standard imaging protocol. Assessment of TAPSE and RV fractional area change will be done. | Collected at birth and at 12 months follow up visit after birth of each child | |
Secondary | Cardiac function offspring - Diastolic function, left ventricular E/A-ratio | ECG and echocardiography will be performed according to standard imaging protocol. Assessment of left ventricular E/A-ratio will be done. | Collected at birth and at 12 months follow up visit after birth of each child | |
Secondary | Cardiac function offspring - Diastolic function, tissue velocities (E', A', S') | ECG and echocardiography will be performed according to standard imaging protocol. Assessment of tissue velocities (E', A', S') will be done. | Collected at birth and at 12 months follow up visit after birth of each child | |
Secondary | Cardiac function offspring - Diastolic function, strain | ECG and echocardiography will be performed according to standard imaging protocol. Assessment of strain will be done. | Collected at birth and at 12 months follow up visit after birth of each child | |
Secondary | Cardiac function offspring - Overall cardiac function | ECG and echocardiography will be performed according to standard imaging protocol. Assessment of Myocardial performance index (MPI) and cardiac torsion will be done. | Collected at birth and at 12 months follow up visit after birth of each child | |
Secondary | Cardiac function offspring - Pulmonary artery acceleration time | ECG and echocardiography will be performed according to standard imaging protocol. Assessment of Pulmonary artery acceleration time will be done. | Collected at birth and at 12 months follow up visit after birth of each child | |
Secondary | Cardiac function offspring - Pulmonary artery pressure | ECG and echocardiography will be performed according to standard imaging protocol. Assessment of Pulmonary artery pressure will be done. | Collected at birth and at 12 months follow up visit after birth of each child | |
Secondary | Cardiac function offspring - Persistent ductus arteriosus (PDA) | ECG and echocardiography will be performed according to standard imaging protocol. Assessment of PDA open or closed and PDA shunt will be done. | Collected at birth and at 12 months follow up visit after birth of each child | |
Secondary | Cord blood - Telomore length | Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for Telomore length. | Collected at birth of both offsprings | |
Secondary | Cord blood - pH | Cord blood will be drawn immediately after birth. pH will be assessed. | Collected at birth | |
Secondary | Cord blood - Epigenetics | Epigenetics analyses from whole blood. Will be analysed for methylation changes. metabolomics and exosome. | Collected at birth of both offsprings | |
Secondary | Adult body composition by DEXA scan | Lean mass (g), fat mass (g), abdominal fat (g), visceral fat (g) assessed by a Dual-energy X-ray absorptiometry (DEXA) -scan . | Collected at study visits 3, 12 and 24 months pp. of 1st child | |
Secondary | Adult bone markers by DEXA scan - bone mineral content | Bone mineral content (g) assessed by a Dual-energy X-ray absorptiometry-scan. | Collected at study visits 3, 12 and 24 months pp. of 1st child | |
Secondary | Adult bone markers by DEXA scan - bone area | Bone area (cm^2) assessed by a Dual-energy X-ray absorptiometry-scan. | Collected at study visits 3, 12 and 24 months pp. of 1st child | |
Secondary | Adult bone markers by DEXA scan - bone mineral density | Bone mineral density (g/cm^2) assessed by a Dual-energy X-ray absorptiometry-scan. | Collected at study visits 3, 12 and 24 months pp. of 1st child | |
Secondary | Adult blood sample - glucose | All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for glucose | Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child | |
Secondary | Adult blood sample - CD163 | All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for CD163 | Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child | |
Secondary | Adult blood sample - HbA1c | All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for markers of glucose metabolism HbA1c | Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child | |
Secondary | Adult blood sample - Kreatinin | All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for kreatinin | Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child | |
Secondary | Adult blood sample - eGFR | All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for kreatinin and GFR will be estimated | Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child | |
Secondary | Adult blood sample - C-reaktivt protein (CRP) | All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for CRP | Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child | |
Secondary | Adult blood sample - Alanintransaminase (ALAT) | All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for ALAT | Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child | |
Secondary | Adult blood sample - Gamma-GT (GGT) | All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for GGT | Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child | |
Secondary | Adult blood sample - Basisk fosfatase (BASP) | All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for BASP | Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child | |
Secondary | Adult blood sample - Bilirubin | All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for Bilirubin | Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child | |
Secondary | Adult blood sample - Ferritin | All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for Ferritin | Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child | |
Secondary | Adult blood sample - Hemoglobin | All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for Hemoglobin | Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child | |
Secondary | Adult blood sample - Leukocytter | All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for Leucocytter | Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child | |
Secondary | Adult blood sample - platelets | All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for platelets | Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child | |
Secondary | Adult blood sample - Triglyceride | All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for triglyceride | Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child | |
Secondary | Adult blood sample - Cholesterol HDL | All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for Cholesterol HDL | Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child | |
Secondary | Adult blood sample - Cholesterol LDL | All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for Cholesterol LDL | Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child | |
Secondary | Adult blood sample - Total Cholesterol | All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for Total Cholesterol | Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child | |
Secondary | Adult blood sample - vitamin B12 | All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for B12 | Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child | |
Secondary | Adult blood sample - vitamin D3 | All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for vitamin D3 | Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child | |
Secondary | Adult blood sample - c-peptide | All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for c-peptide | Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child | |
Secondary | Adult blood sample - Insulin-like Growth Factor-1 (IGF-1) | All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for IGF-1 | Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child | |
Secondary | Adult blood sample - Insulin-like growth factor-binding protein-1 (IGFBP-1) | All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for IGFBP-1 | Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child | |
Secondary | Adult blood sample - Insulin-like growth factor-binding protein-3 (IGFBP-3) | All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for IGFBP-3 | Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child | |
Secondary | Adult blood sample - Fibroblast growth factor 21 (FGF-21) | All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for FGF-21 | Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child | |
Secondary | Adult blood sample - Leptin | All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for Leptin | Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child | |
Secondary | Adult blood sample - Adiponectin | All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for Adiponectin | Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child | |
Secondary | Adult blood sample - Ghrelin | All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for Ghrelin | Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child | |
Secondary | Adult blood sample - Growth Hormone (GH) | All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for GH | Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child | |
Secondary | Adult blood sample - Free fatty Acids (FFA) | All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for FFA | Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child | |
Secondary | Adult blood sample - Interleukin 6 (IL-6) | All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for IL-6 | Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child | |
Secondary | Adult blood sample - Interleukin 6 (IL-10) | All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for IL-10 | Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child | |
Secondary | Adult blood sample - Interleukin-1 alpha (IL-1 alpha) | All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for IL-1 alpha | Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child | |
Secondary | Adult blood sample - Interferon gamma (IFN-?) | All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for IFN-? | Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child | |
Secondary | Adult blood sample - Tumor Necrosis Factor alfa (TNF-a) | All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for TNF-a | Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child | |
Secondary | Adult female blood sample - Humant choriogonadotropin (hCG) | All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will only be collected from the female participant during pregnancy and be analysed for hCG | Collected at GA34-GA36 in both pregnancies | |
Secondary | Adult female blood sample - Progesterone | All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will only be collected from the female participant during pregnancy and be analysed for Progesterone | Collected at GA34-GA36 in both pregnancies | |
Secondary | Adult female blood sample - Proinsulin C-peptide | All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will only be collected from the female participant during pregnancy and be analysed for Proinsulin C-peptide | Collected at GA34-GA36 in both pregnancies | |
Secondary | Adult female blood sample - sex hormone binding globulin (SHBG) | All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will only be collected from the female participant during pregnancy and be analysed for SHBG | Collected at GA34-GA36 in both pregnancies | |
Secondary | Adult female blood sample - Prolactin | All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will only be collected from the female participant during pregnancy and be analysed for Prolactin | Collected at GA34-GA36 in both pregnancies | |
Secondary | Adult blood sample -Cortisol | All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for Cortisol | Collected at GA34-GA36 in both pregnancies | |
Secondary | Adult female blood sample -Estradiol | All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will only be collected from the female participant during pregnancy and be analysed for Estradiol | Collected at GA34-GA36 in both pregnancies | |
Secondary | Offspring blood sample - glucose | A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for glucose | Collected 12 months after birth in both offsprings | |
Secondary | Offspring blood sample - c-peptide | A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for c-peptide | Collected 12 months after birth in both offsprings | |
Secondary | Offspring blood sample - insulin | A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for Insulin | Collected 12 months after birth in both offsprings | |
Secondary | Offspring blood sample - IGF-1 | A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for IGF-1 | Collected 12 months after birth in both offsprings | |
Secondary | Offspring blood sample - IGFBP-3 | A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for IGFBP-3 | Collected 12 months after birth in both offsprings | |
Secondary | Offspring blood sample - IGFBP-1 | A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for IGFBP-1 | Collected 12 months after birth in both offsprings | |
Secondary | Offspring blood sample - CD163 | A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for CD163 | Collected 12 months after birth in both offsprings | |
Secondary | Offspring blood sample - Ferritin | A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for Ferritin | Collected 12 months after birth in both offsprings | |
Secondary | Offspring blood sample - HgbA1c | A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for HgbA1c | Collected 12 months after birth in both offsprings | |
Secondary | Offspring blood sample - Hgb | A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for Hgb | Collected 12 months after birth in both offsprings | |
Secondary | Offspring blood sample - CRP | A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for CRP | Collected 12 months after birth in both offsprings | |
Secondary | Offspring blood sample - Triglyceride | A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for Triglyceride | Collected 12 months after birth in both offsprings | |
Secondary | Offspring blood sample - Cholesterol HDL | A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for Cholesterol HDL | Collected 12 months after birth in both offsprings | |
Secondary | Offspring blood sample - Cholesterol LDL | A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for Cholesterol LDL | Collected 12 months after birth in both offsprings | |
Secondary | Offspring blood sample - Total Cholesterol | A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for Total Cholesterol | Collected 12 months after birth in both offsprings | |
Secondary | Offspring blood sample - FGF-21 | A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for FGF-21 | Collected 12 months after birth in both offsprings | |
Secondary | Offspring blood sample - Leptin | A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for Leptin | Collected 12 months after birth in both offsprings | |
Secondary | Offspring blood sample - Adiponectin | A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for Adiponectin | Collected 12 months after birth in both offsprings | |
Secondary | Offspring blood sample - FFA | A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for FFA | Collected 12 months after birth in both offsprings | |
Secondary | Offspring blood sample - Growth Hormone (GH) | A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for GH | Collected 12 months after birth in both offsprings | |
Secondary | Offspring blood sample - cTroponin I (cTnI) | A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for cTnI | Collected 12 months after birth in both offsprings | |
Secondary | Offspring blood sample - BNP | A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for BNP | Collected 12 months after birth in both offsprings | |
Secondary | Cord blood - c-peptide | Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for C-peptide | Collected at birth of both offspring | |
Secondary | Cord blood -Insulin | Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for Insulin | Collected at birth of both offspring | |
Secondary | Cord blood -IGFBP-3 | Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for IGFBP-3 | Collected at birth of both offspring | |
Secondary | Cord blood -IGFBP-1 | Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for IGFBP-1 | Collected at birth of both offspring | |
Secondary | Cord blood -IGF-1 | Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for IGF-1 | Collected at birth of both offspring | |
Secondary | Cord blood -Ferritin | Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for Ferritin | Collected at birth of both offspring | |
Secondary | Cord blood -cTnI | Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for cTnI | Collected at birth of both offspring | |
Secondary | Cord blood -BNP | Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for BNP | Collected at birth of both offspring | |
Secondary | Cord blood -CRP | Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for CRP | Collected at birth of both offspring | |
Secondary | Cord blood -CD163 | Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for CD163 | Collected at birth of both offspring | |
Secondary | Cord blood -FGF21 | Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for FGF21 | Collected at birth of both offspring | |
Secondary | Cord blood -Leptin | Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for Leptin | Collected at birth of both offspring | |
Secondary | Cord blood -Adiponectin | Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for Adiponectin | Collected at birth of both offspring | |
Secondary | Cord blood -FFA | Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for FFA | Collected at birth of both offspring | |
Secondary | Cord blood - Vitamin D3 | Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for Vitamin D3 | Collected at birth of both offspring | |
Secondary | Cord blood - HbA1c | Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for HbA1c | Collected at birth of both offspring | |
Secondary | Cord blood - IL-6 | Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for IL-6 | Collected at birth of both offspring | |
Secondary | Cord blood - IL-10 | Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for IL-10 | Collected at birth of both offspring | |
Secondary | Cord blood - IL-1 alpha | Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for IL-1 alpha | Collected at birth of both offspring | |
Secondary | Cord blood -TNF- alpha | Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for-TNF- alpha | Collected at birth of both offspring | |
Secondary | Cord blood -IFN- gamma | Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for IFN- gamma | Collected at birth of both offspring |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT03994419 -
PErioperAtive CHildhood ObesitY
|
||
Recruiting |
NCT05354245 -
Using a Complex Carbohydrate Mixture to Steer Fermentation and Improve Metabolism in Adults With Overweight and Prediabetes (DISTAL)
|
N/A | |
Completed |
NCT03602001 -
Attentive Eating for Weight Loss
|
N/A | |
Recruiting |
NCT06269159 -
The Power of 24-hour: Co-designing Intervention Components
|
||
Completed |
NCT03377244 -
Healthy Body Healthy Souls in the Marshallese Population
|
N/A | |
Completed |
NCT02996864 -
Location-based Smartphone Technology to Guide College Students Healthy Choices Ph II
|
N/A | |
Completed |
NCT04647149 -
Effects of Early and Delayed Time-restricted Eating in Adults With Overweight and Obesity
|
N/A | |
Terminated |
NCT03914066 -
A Group-based Treatment of Overweight and Obesity in Primary Care
|
N/A | |
Completed |
NCT03685656 -
Effect of ANACA3 Slimming Gel on Loss of Abdominal and Thigh Circumferences in Healthy Volunteers
|
N/A | |
Completed |
NCT05051579 -
A Study of LY3502970 in Participants With Obesity or Overweight With Weight-related Comorbidities
|
Phase 2 | |
Completed |
NCT04611477 -
Effect of Synbiotic 365 on Body Composition in Overweight and Obese Individuals
|
N/A | |
Active, not recruiting |
NCT05330247 -
Cut Down on Carbohydrate in the Dietary Therapy of Type 2 Diabetes - The Meal Box Study
|
N/A | |
Completed |
NCT03599115 -
Effects of Inhibitory Control Training in Eating Behaviors
|
N/A | |
Recruiting |
NCT06094231 -
Treating Patients With Renal Impairment and Altered Glucose MetAbolism With TherapeutIc Carbohydrate Restriction and Sglt2-Inhibiton - a Pilot Study
|
N/A | |
Recruiting |
NCT05938894 -
Train Your Brain - Executive Function
|
N/A | |
Recruiting |
NCT05987306 -
A Self-compassion Focused Intervention for Internalized Weight Bias and Weight Loss
|
N/A | |
Completed |
NCT03792685 -
Looking for Personalized Nutrition for Obesity/Type 2 Diabetes Mellitus Prevention
|
N/A | |
Completed |
NCT05055362 -
Effect a Honey, Spice-blended Baked Good Has on Salivary Inflammation Markers in Adults: a Pilot Study
|
N/A | |
Completed |
NCT04520256 -
Rapid Evaluation of Innovative Intervention Components to Maximize the Health Benefits of Behavioral Obesity Treatment Delivered Online: An Application of Multiphase Optimization Strategy
|
Phase 2/Phase 3 | |
Completed |
NCT04979234 -
A Single Centre, Prospective Feasibility Study to Evaluate the Efficacy of an Endoluminal-suturing Device (Endomina) on Severe Obstructive Sleep Apnea Syndrome
|
N/A |